Drug Interaction Study of SAR302503 in Patients With Solid Tumor

NCT01585623 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

16

Enrollment

INDUSTRY

Sponsor class

Conditions

Solid Tumor

Interventions

DRUG: SAR302503
DRUG: omeprazol
DRUG: metoprolol
DRUG: midazolam

Sponsor

Bristol-Myers Squibb